-
1.SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS 有权
Title translation: SPIRO-OXINDOLE化合物及其作为治疗剂的用途公开(公告)号:US20120295897A1
公开(公告)日:2012-11-22
申请号:US13557833
申请日:2012-07-25
Applicant: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
Inventor: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
IPC: A61K31/407 , A61K31/429 , C07D491/20 , A61K31/4439 , A61K31/422 , C07D498/20 , A61K31/424 , A61K31/5383 , C07D491/107 , A61K31/475 , C07D495/20 , A61K31/4245 , A61K31/4985 , A61K31/4178 , A61K31/4155 , A61K31/5377 , A61K31/427 , A61K31/433 , A61K31/497 , A61K31/506 , A61K31/454 , A61K31/41 , A61K31/496 , A61P29/00 , A61P25/24 , A61P9/00 , A61P11/00 , A61P25/18 , A61P3/06 , A61P35/00 , A61P17/04 , C07D513/20
CPC classification number: C07D513/22 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/20 , C07D498/20 , C07D513/20 , C07D519/00
Abstract: This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Abstract translation: 本发明涉及螺 - 羟吲哚化合物,作为立体异构体,对映体,其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-
2.Spiro-oxindole compounds and their uses as therapeutic agents 有权
Title translation: 螺 - 羟吲哚化合物及其作为治疗剂的用途公开(公告)号:US08415370B2
公开(公告)日:2013-04-09
申请号:US13557833
申请日:2012-07-25
Applicant: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
Inventor: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
IPC: A61K31/44 , C07D213/02
CPC classification number: C07D513/22 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/20 , C07D498/20 , C07D513/20 , C07D519/00
Abstract: This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Abstract translation: 本发明涉及螺 - 羟吲哚化合物,作为立体异构体,对映体,其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-